TNF Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Summary of Change in Fair Value of Warrant Liabilities (Details) - USD ($)		3 Months Ended				12 Months Ended
	Jul. 07, 2022	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities, beginning balance
Issuance of warrants reported at fair value						10,623,000
Change in fair value of Warrant Liabilities	$ 84,851					(9,756,000)
Warrant liability, ending balance		$ 867,000				867,000
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities, beginning balance		2,457,000	$ 7,813,000	$ 9,448,000
Issuance of warrants reported at fair value					10,623,000
Change in fair value of Warrant Liabilities		(1,590,000)	(5,356,000)	(1,635,000)	(1,175,000)
Warrant liability, ending balance		$ 867,000	$ 2,457,000	$ 7,813,000	$ 9,448,000	$ 867,000